Ei­sai ter­mi­nates Phase 3 tri­al of Dravet drug, cit­ing re­cruit­ment chal­lenges

Ei­sai has stopped the Phase 3 clin­i­cal de­vel­op­ment of an ad­junc­tive treat­ment for Dravet syn­drome, a spokesper­son con­firmed to End­points News on Fri­day af­ter­noon. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER